The health tech market is projected to grow from $240 billion in 2022 to $1043 billion by 2030. Technologies like EHRs, e-prescribing, and telehealth aim to simplify tasks for providers and patients.

The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found ...

colposcopy exam through high-resolution imagery and easy-to-read color-coded maps of the cervix provided by DYSIS technology. “The new DYSIS technology helps us better pinpoint questionable areas on ...

BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, and Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage ...

BOSTON--(BUSINESS WIRE)--Ontada®, a McKesson business dedicated to oncology real-world data and evidence, clinical education, and point of care technologies, today announced that it is collaborating ...

The 3D cell culture market is projected to grow by more than 14% annually, from $1.4 billion in 2022 to nearly $5.3 billion annually by 2032 1 PITTSBURGH, June 04, 2024 (GLOBE NEWSWIRE) -- Predictive ...

Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments. Twenty-five years have passed ...

Please provide your email address to receive an email when new articles are posted on . A viewpoint paper outlined the benefits of a well-coordinated patient-reported outcomes collection system. The ...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has ...

Fort Myers, Fla.-based 21st Century Oncology has agreed to pay HHS’ Office for Civil Rights a $2.3 million settlement to resolve issues related to a 2015 data breach that affected 2.2 million patient ...

This licensing deal falls under the biotech’s wider ploy to harness the promise of radiopharmaceuticals within the oncology ...